Correction: Chronic administration of Metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cells
Francesca Cianci, Ivan Verduci, Riccardo Cazzoli, Gaetano Cannavale, Guido Rey, Marina Veronesi, Beatrice Balboni, Matteo Ranucci, Luca Maria Giovanni Palloni, Federico Ballabio, Noemi Barsotti, Giorgia Ailuno, Alice Balboni, Sara Baldassari, Gabriele Caviglioli
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMetabolism, Diabetes, and Cancer · PI3K/AKT/mTOR signaling in cancer · Biological Research and Disease Studies
Correction: J Exp Clin Cancer Res 44,** 312 (2025)**
https://doi.org/10.1186/s13046-025-03577-3
Following publication of the original article [1], the authors would like to correct the affiliation of Dr. Saverio Minucci. The details are given below:
Current affiliation: ^2^IEO, Istituto Europeo di Oncologia, Milano, Italy
Correct affiliation: ^16^Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan